Riskpilot← Back to searchSign inGet full accessWulf Science AB
ABActiveOrg 5569042434Baldersgatan 18Engineering activities and related technical consultancy · NACE 7112Est. 20121 employees
Revenue 2024
SEK 2,6M
+25% vs 2023
EBITDA margin
9.7%
+591% vs 2023
Equity ratio
32.0%
Financial strength
Net profit 2024
SEK 170K
+931% vs 2023
| Revenue | SEK 2,6M | +25% |
| EBITDA | SEK 250K | +591% |
| Net profit | SEK 170K | +931% |
| Total assets | SEK 813K | -2% |
| Equity | SEK 260K | +190% |
| Employees | 1 | — |
Legal name
Wulf Science AB
Org number
5569042434
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
19 september 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget har en hållbarhetsprofil och bedriver verksamhet inom innovation, mjukvara och textproduktion, samt erbjuder konsulttjänster med inriktning mot företagsutveckling, kommunikation och systemdesign.
Address
Baldersgatan 18
Phone
+4611122090
Email
info@wulf.science
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 | 40 | 75 | 2 066 | 2 579 |
| Staff expenses | — | — | — | −1 401 | −1 547 |
| EBITDA | −18 | 2 | −9 | 36 | 250 |
| Depreciation & amort. | −0 | −0 | — | −18 | −33 |
| EBIT | −18 | 2 | −9 | 18 | 217 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −18 | 2 | −9 | 18 | 217 |
| Tax | −0 | −0 | — | −1 | −47 |
| Net profit | −18 | 2 | −9 | 17 | 170 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 93 | 96 | 80 | 832 | 813 |
| Equity | 81 | 82 | 73 | 90 | 260 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 12 | 14 | 7 | 743 | 553 |
| Total debt | 12 | 14 | 7 | 743 | 553 |
EBITDA margin
9.7%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
32.0%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
65.6%
This company
18.4%
Market median
+257% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
3.17×
This company
1.12×
Market median
+183% vs market
20202024
Debt / equity
2.13×
This company
0.62×
Market median
-244% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
SM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wulf Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gustav Sören Wulf | Deputy Chief Executive Officer | 0 companies |
| Sara Matilda Torstensson Wulf | Chief Executive Officer | 0 companies |
| Johan Selinder | Deputy Board Member | 0 companies |